ロード中...
Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure
Patients with systemic lupus erythematosus (SLE) have an increased risk of developing osteoporosis and fractures due to systemic inflammation and glucocorticoids (GCs). Professional organizations recommend bone mineral density (BMD) testing in SLE patients on GCs, especially within 6 months of initi...
保存先:
| 出版年: | Lupus |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933066/ https://ncbi.nlm.nih.gov/pubmed/33307984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203320979735 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|